Digitally-Augmented Drugs: A Practical Experience for Growing Pharma Portfolios



Drug development is increasingly complex and expensive for pharmaceutical companies. “Digitally-augmenting drugs” is one of the strategies to secure the value of drug assets. As the field is moving fast, we hosted an online discussion with seasoned industry executives who pioneered the space of digital/drug combinations during the past decade. They shared key learnings from their practical experience that we summarized in this one-pager. Feel-free to share your thoughts and join the conversation by contacting our team.

Download the one-pager now!

  • * Required information The mandatory fields above are necessary for Voluntis to process your contact request. If you do not fill them in, your request cannot be processed. To find out more about the use of your personal data and how to exercise your rights, please consult the Privacy Policy
  • This field is for validation purposes and should be left unchanged.